Skip to main content

UPDATE 1-Eli Lilly to delay new studies due to coronavirus outbreak

U.S. drugmaker Eli Lilly & Co said on Monday it would delay starting new studies and pause enrollment in ongoing studies, as it looks to free up healthcare facilities and doctors to attend to the growing number of COVID-19 patients.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.